The coronavirus outbreak is sparking fears of drug shortages in the U.S., largely due to its disruption of pharmaceutical supplies from China and India.
USP in the News
USA Today
Coronavirus spurs fears of drug shortages as outbreak disrupts the medicine supply chain
Forbes
Coronavirus Outbreak Will Lead To More Drug Shortages In The U.S., Including Antibiotics
The FDA released a statement saying the U.S. was experiencing its first drug shortage directly related to the coronavirus outbreak.
News Releases & Announcements
Quality Matters Blog
What does the future of health IT look like?
The digitization of healthcare must be effectively structured to optimize care, therapies, access, and outcomes.
USP volunteers help shape the future of drug manufacturing
Consistent quality. Greater access. They’re what patients deserve and what USP strives to ensure across the globe through the development of public quality standards.
A new generation of tools and standards for biologic medicine quality
USP standards have evolved to accommodate medicines of all types. The biosimilar paradigm may ultimately resemble that of generic drugs.
Stay Connected…
Sign up for the latest USP News Releases!